---
schema_version: "secwatch.filing_event.v1"
accession: "0000310764-22-000008"
form_type: "8-K"
ticker: "SYK"
cik: "0000310764"
company_name: "STRYKER CORP"
filed_at: "2022-01-27T23:59:59+00:00"
generated_at: "2026-06-27T15:06:45.937335+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Stryker Q4 sales $4.7B (+10.3%), FY21 adj. EPS $9.09 (+22.3%); forecasts FY22 adj. EPS $9.60-10.00

## Summary
- Q4 net sales $4.7B, +10.3% YoY; organic +9.0% vs 2020, +6.2% vs 2019.
- Q4 reported EPS $1.73 (+16.1%); adjusted EPS $2.71 (-3.6%) year-over-year.
- Full-year net sales $17.1B, +19.2% YoY; reported EPS $5.21 (+24.0%); adjusted EPS $9.09 (+22.3%).
- MedSurg & Neurotech FY organic sales +13.1%; Orthopaedics & Spine FY organic +12.0%.
- 2022 outlook: organic sales growth 6%-8%; adjusted EPS $9.60-$10.00; expects ~1% price headwind.

## SEC filing metadata
- accession: 0000310764-22-000008
- form_type: 8-K
- ticker: SYK
- cik: 0000310764
- company_name: STRYKER CORP
- filed_at: 2022-01-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310764/000031076422000008/0000310764-22-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310764/000031076422000008/syk-20220127.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000310764-22-000008
- JSON: https://secwatch.observer/filing/0000310764-22-000008.json
- Plain text: https://secwatch.observer/filing/0000310764-22-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.